Form 4: Altimmune Executive Receives Stock Grant
Insider Transaction (Form 4)
Richard Thomas Menziuso, Principal Accounting Officer of Altimmune, Inc., reported multiple transactions in common stock on October 1, 2026.
Summary
- Grant/award: acquired 84,546 Stock Options (option to buy) on October 1, 2026; holds 84,546 after (Direct).
- Grant/award: acquired 36,234 Restricted Stock Units on October 1, 2026; holds 36,234 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Richard Thomas Menziuso — Officer (Principal Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Stock Options (option to buy) | 84,546 | — | — | 84,546 |
| 2026-10-01 | Grant/award | Restricted Stock Units | 36,234 | — | — | 36,234 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (84,546 shares) |
| 2026-10-01 | Grant/award (36,234 shares) |
Keywords
insider transaction, Form 4, ALT, Altimmune, Inc., neutral, Richard Thomas Menziuso
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.